Abridge Secures $250M Series D Amid Rapid Health System Expansion
Key Highlights Abridge secures $250M Series D co-led by Elad Gil and IVP, with backing from top investors including…
Browsing Tag
NVIDIA
9 posts
Hippocratic AI Secures $17 Million Investment from NVentures
Key Highlights Hippocratic AI raises $17M from NVentures, Greycroft, and Leo Shapiro. Total Series A investment reaches $137M at a $500 million valuation. NVIDIA NIM microservices to scale Hippocratic…
CytoReason Secures $80 Million to Advance Computational Disease Models
Key Highlights $80 million funding secured from OurCrowd, NVIDIA, Pfizer, and Thermo Fisher. Investment to expand AI disease…
Mendel AI Joins NVIDIA Inception to Advance Clinical AI Solutions
Key Highlights Mendel AI partners with NVIDIA Inception to enhance clinical AI solutions. Access to NVIDIA’s leading technology and expertise…
EvolutionaryScale Unveils ESM3: A Milestone in AI-Driven Protein Engineering
Key Highlights EvolutionaryScale launches ESM3, an advanced AI model. ESM3 creates a new Green Fluorescent Protein (GFP). Simulates…
Dyno Therapeutics Teams Up with NVIDIA for AI-Driven Drug Design
Key Highlights Dyno Therapeutics and NVIDIA partner to leverage AI and advanced computing for drug development. Utilization of NVIDIA’s…
Artisight Secures $42 Million in Oversubscribed Series B Funding to Revolutionize Healthcare with AI
Key Highlights Raised $42 million in an oversubscribed Series B funding round, with participation from strategic and client health…
Marc Yoskowitz Takes Helm as CEO at Evozyne to Propel AI-Driven Drug Discovery
Key Highlights Marc Yoskowitz appointed as CEO of Evozyne, bringing extensive leadership from Tempus AI, Pfizer, and McKinsey.…
Genentech and NVIDIA Forge Strategic Alliance to Revolutionize Drug Discovery with AI
Key Highlights Strategic collaboration between Genentech and NVIDIA focuses on utilizing AI for faster drug discovery and development. Integration…